Mohit Butaney
Henry Ford Health System(US)Henry Ford Hospital(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, Prostate Cancer Diagnosis and Treatment
Most-Cited Works
- → Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors(2013)1,232 cited
- → Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis(2011)896 cited
- → Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA(2014)776 cited
- → Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer(2013)602 cited
- → A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors(2011)600 cited
- → A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response(2012)448 cited
- → Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non–Small Cell Lung Cancer(2013)368 cited
- → Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions(2013)352 cited
- → Dissemination of Misinformative and Biased Information about Prostate Cancer on YouTube(2018)349 cited
- → Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers(2019)297 cited